The suppressive effect of resveratrol on HIF-1α and VEGF expression after warm ischemia and reperfusion in rat liver

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zhang, Mei ^a   Li , Wujun ^b   Yu, Liang ^a   Wu, Shengli ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RESVERATROL; VASCULOTROPIN; MESSENGER RNA; STILBENE DERIVATIVE; VASCULOTROPIN A;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIOCHEMISTRY; CONTROLLED STUDY; ENZYME REPRESSION; ISCHEMIA; LIVER; LIVER FUNCTION; MALE; NONHUMAN; PROTEIN DENATURATION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; WESTERN BLOTTING; ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

RATTUS;

ANIMALS; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RNA, MESSENGER; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WARM ISCHEMIA;

EID: 84907833268     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109589     Document Type: Article

References (30)

1. Bosch FX, Ribes J, Diaz M, Cleries R (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology 127: S5-S16.
2. Zhang Y, Shi ZL, Yang X, Yin ZF (2014) Targeting of circulating hepatocellular carcinoma cells to prevent postoperative recurrence and metastasis. World J - Gastroenterol 20: 142-147.
3. Li CX, Shao Y, Ng KT, Liu XB, Ling CC, et al. (2012) FTY720 suppresses liver tumor metastasis by reducing the population of circulating endothelial progenitor cells. PLoS One 7: e32380.
4. Cursio R, Miele C, Filippa N, Van Obberghen E, Gugenheim J (2008) Liver HIF-1 alpha induction precedes apoptosis following normothermic ischemiareperfusion in rats. Transplant Proc 40: 2042-2045.
5. van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, et al. (2005) Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 42: 165- 175.
6. Knudsen AR, Kannerup AS, Grønbæk H, Andersen KJ, Funch-Jensen P, et al. (2011) Effects of ischemic pre- And postconditioning on HIF-1a, VEGF and TGF-b expression after warm ischemia and reperfusion in the rat liver. Comp Hepatol 10: 3.
7. Boros P, Tarcsafalvi A, Wang L, Megyesi J, Liu J, et al. (2001) Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation 72: 805-811.
8. Tamagawa K, Horiuchi T, Uchinami M, Doi K, Yoshida M, et al. (2008) Hepatic ischemia-reperfusion increases vascular endothelial growth factor and cancer growth in rats. J Surg Res 148: 158-163.
9. Chai ZT, Kong J, Zhu XD, Zhang YY, Lu L, et al. (2013) MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2a/Akt/HIF-1a pathway in hepatocellular carcinoma. PLoS One 8: e77957.
10. An X, Xu G, Yang L, Wang Y, Li Y, et al. (2014) Expression of hypoxiainducible factor-1a, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features. J Dermatol 41: 76-83.
11. Shi D, Xie F, Zhang Y, Tian Y, Chen W, et al. (2014) TFAP2A Regulates Nasopharyngeal Carcinoma Growth and Survival by Targeting HIF-1a Signaling Pathway. Cancer Prev Res (Phila) 7: 266-277.
12. Soleas GJ, Diamandis EP, Goldberg DM (1997) Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 11: 287-313.
13. Singh CK, George J, Ahmad N (2013) Resveratrol-based combinatorial strategies for cancer management. Ann N Y Acad Sci 1290: 113-121.
14. Aziz MH, Kumar R, Ahmad N (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms. Int J Oncol 23: 17- 28.
15. Wen D, Huang X, Zhang M, Zhang L, Chen J, et al. (2013) Resveratrol attenuates diabetic nephropathy via modulating angiogenesis. PLoS One 8: e82336.
16. Shin T, Kuboki S, Huber N, Eismann T, Galloway E, et al. (2008) Activation of peroxisome proliferator-activated receptor-gamma during hepatic ischemia is age-dependent. J Surg Res 147: 200-205.
17. Ito K, Ozasa H, Noda Y, Koike Y, Arii S, et al. (2008) Effect of non-essential amino acid glycine administration on the liver regeneration of partially hepatectomized rats with hepatic ischemia/reperfusion injury. Clin Nutr 27: 773-780.
18. Papadopoulos D, Siempis T, Theodorakou E, Tsoulfas G (2013) Hepatic ischemia and reperfusion injury and trauma: current concepts. Arch Trauma Res 2: 63-70.
19. Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92: 5510-5514.
20. Xu LF, Ni JY, Sun HL, Chen YT, Wu YD (2013) Effects of hypoxia-inducible factor-1a silencing on the proliferation of CBRH-7919 hepatoma cells. World J Gastroenterol 19: 1749-1759.
21. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, et al. (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxiainducible factor-1. J Biol Chem 271: 32529-32537.
22. Vaupel P (2004) The role of hypoxia-induced factors in tumor progression. Oncologist 9: 10-17.
23. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
24. Michalopoulos GK (2007) Liver regeneration. J Cell Physiol 213: 286-300.
25. Wu SL, Yu L, Jiao XY, Meng KW, Pan CE (2006) The suppressive effect of resveratrol on protein kinase C theta in peripheral blood T lymphocytes in a rat liver transplantation model. Transplant Proc 38: 3052-3054.
26. Gedik E, Girgin S, Ozturk H, Obay BD, Ozturk H, et al. (2008) Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats. World J Gastroenterol 14: 7101-7106.
27. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, et al. (2004) Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10: 2190-2202.
28. Yu HB, Zhang HF, Zhang X, Li DY, Xue HZ, et al. (2010) Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism. Hepatogastroenterology 57: 1241-1246.
29. Cao ZX, Fang J, Xia C, Shi XL, Jiang BH (2004) Trans-3, 4, 59-trihydroxystibene inhibits hypoxia-inducible factor-1a and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 10: 5253- 5263.
30. Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, et al. (2005) Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther 4: 1465-1474.